CME Group reported third-quarter 2026 results on October 21, 2026, with revenue of $1.7 billion, up from $1.5 billion a year earlier, and diluted earnings per share of $2.89, up from $2.49. Adjusted diluted EPS was $3.02 versus $2.68 a year earlier, and the company returned nearly $1 billion to shareholders during the quarter.
Q3 2026 total revenues of $1,737.3 million versus $1,537.6 million in Q3 2025
Diluted EPS of $2.89 versus $2.49; adjusted diluted EPS of $3.02 versus $2.68
Average daily volume of 29.4 million contracts, a third-quarter record
Returned nearly $1 billion to shareholders: $465 million in dividends and $524 million in share repurchases
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From CME Group's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$6.52B
+6.4%
$11.16
+15.4%
62.5%
FY2024
$6.13B
+9.9%
$9.67
+9.1%
57.5%
FY2023
$5.58B
+11.1%
$8.86
+19.7%
57.8%
FY2022
$5.02B
+7.0%
$7.40
+1.5%
53.6%
FY2021
$4.69B
-4.0%
$7.29
+24.2%
56.2%
Frequently asked questions
When is CME's next earnings date?
CME has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did CME earn last quarter?
For the quarter ended Sep 2026, CME reported diluted EPS of $2.89 (+16.1% year over year) on revenue of $1.74B (+13.0%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.